GlassScriptPhysician profile
Eugene H Eng
NPI 1760533608
$3,465.77
in general payments reported to CMS, 2019-2025
29 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $184 · 2021: $257 · 2022: $442 · 2023: $442 · 2024: $581 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,112 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,111.52 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,152.41 | 2019-2025 | Clareon, Clareon Panoptix Pro, Lensx |
| Mallinckrodt Hospital Products INC. | $323.85 | 2024-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $303.40 | 2019-2021 | |
| Genentech USA, INC. | $270.77 | 2022-2025 | Vabysmo |
| Allergan, INC. | $125.80 | 2019-2021 | |
| Abbvie INC. | $101.49 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $94.04 | 2022-2024 | Vyzulta, Miebo |
| Ocular Therapeutix, INC. | $84.01 | 2021-2025 | Dextenza |
| Tarsus Pharmaceuticals, INC. | $80.91 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $79.40 | 2019-2025 | Tecnis Simplicity |
| Harrow Eye, LLC | $78.89 | 2024 | Iheezo, Vevye |
| Coopervision INC. | $74.26 | 2025 | Misight Contact Lens |
| Glaukos Corporation | $71.48 | 2019-2025 | Idosetr |
| Rxsight INC | $64.85 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Eyepoint US, INC. | $63.66 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $57.64 | 2024 | Rayone Aspheric, Omidria, Rayone Emv |
| Aerie Pharmaceuticals, INC. | $56.16 | 2019-2020 | |
| Shire North American Group INC | $56.00 | 2019 | |
| Astellas Pharma US INC | $53.45 | 2025 | Izervay |
| Dompe US, INC. | $51.38 | 2024-2025 | Oxervate |
| Omeros Corporation | $40.20 | 2020 | |
| Thea Pharma INC. | $39.94 | 2024-2025 | Iyuzeh |
| Amgen INC. | $32.72 | 2024-2025 | Tepezza |
| Regeneron Healthcare Solutions, INC. | $26.60 | 2024 | Eylea Hd |
| Kala Pharmaceuticals, INC. | $19.80 | 2022 | |
| Sun Pharmaceutical Industries INC. | $17.96 | 2025 | |
| Biotissue Holdings INC. | $16.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.74 | 2021 | |
| Horizon Therapeutics Plc | $12.82 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Eng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.